cbdMD, Inc. (YCBD) intrinsic value & 10-year financials
cbdMD, Inc. (YCBD) has a Graham intrinsic value of $9.30 per share. At $0.36 on Oct 17, 2026, the stock trades 96% below that value. Over the last 10 fiscal years revenue grew 28.3% a year to $19.2M, with an average return on invested capital of -166.1%.
- Graham intrinsic value
- $9.30
- Share price (Oct 17, 2026)
- $0.36
- Price vs Graham value
- 96% below
- Market cap
- $1.4M
- Revenue (FY2025)
- $19.2M
- Revenue growth (10-yr CAGR)
- 28.3%
- ROIC (10-yr avg)
- -166.1%
- Free cash flow (FY2025)
- -$1.6M
YCBD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $19.2M | -$2.0M | -$1.09 | -$1.6M | -11.3% | -96.6% |
| FY2024 | $19.9M | -$3.7M | -$1.79 | -$542.8K | -16.6% | -72.5% |
| FY2023 | $25.1M | -$22.9M | -$13.32 | -$4.6M | -89.8% | -117.9% |
| FY2022 | $37.1M | -$70.1M | -$1.24 | -$15.7M | -210.8% | -142.0% |
| FY2021 | $47.3M | -$23.4M | -$0.47 | -$14.4M | -41.4% | -25.8% |
| FY2020 | $41.9M | $12.6M | $0.28 | -$12.0M | -42.0% | -34.0% |
| FY2019 | $23.7M | -$51.4M | $0.00 | $14.2M | -62.6% | -43.0% |
| FY2018 | $8.4M | $62.8K | $0.00 | -$5.6M | 0.6% | 0.4% |
| FY2017 | $4.5M | -$1.4M | — | -$2.3M | -30.4% | -59.5% |
| FY2016 | $2.0M | -$3.9M | — | -$3.0M | -191.4% | -1069.9% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
cbdMD, Inc. is a consistent compounder, expanding top-line revenue at 28.3% annually over the past decade.
cbdMD, Inc. has historically struggled to out-earn its cost of capital, averaging just -60.2% ROIC.
cbdMD, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, cbdMD, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $9.30 per share.